The macroeconomics of AI capacity: insights from a two-asset growth model
Macroeconomic Dynamics · 2026 · 30
DOI: 10.1017/s1365100526100911 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macroeconomic Dynamics, online erschienen am 26.03.2026. Verfasst von Jonathan Rice. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Specialised AI hardware becomes economically obsolete much faster than conventional capital, so maintaining a given stock of compute requires high replacement investment. This paper studies the implications for growth, adjustment dynamics, and policy in a two-asset growth model in which AI capacity both raises productivity and produces digital services at low marginal cost. Calibrated to advanced economies, the model delivers two distinct adjustment speeds. AI capacity reverts relatively quickly, with a half-life of about seven quarters, while conventional capital adjusts over roughly a decade. When hardware is short-lived, even modest changes in gross spending can produce large swings in measured AI investment, despite only limited movements in the underlying stock. This helps explain the volatility often seen in specialised AI hardware investment cycles. Hardware durability also has first-order welfare effects. In the baseline calibration, a two-percentage-point fall in quarterly depreciation raises welfare by 0.36% in consumption-equivalent terms, while an equal-sized compute tax reduces the steady-state AI stock by around one-fifth.
Zitieren
APA
Rice, J. (2026). The macroeconomics of AI capacity: insights from a two-asset growth model. Macroeconomic Dynamics, 30. https://doi.org/10.1017/s1365100526100911
Vancouver
Rice J. The macroeconomics of AI capacity: insights from a two-asset growth model. Macroeconomic Dynamics. 2026;30. doi:10.1017/s1365100526100911
BibTeX
@article{Rice2026,
author = {Rice, Jonathan},
title = {The macroeconomics of AI capacity: insights from a two-asset growth model},
journal = {Macroeconomic Dynamics},
year = {2026},
volume = {30},
doi = {10.1017/s1365100526100911}
}
EUVIMED